Alembic Pharmaceuticals Share Price
Start SIP in Alembic Pharmaceuticals
Start SIPAlembic Pharmaceuticals Performance
Day Range
- Low 1,186
- High 1,224
52 Week Range
- Low 707
- High 1,285
- Open Price1,205
- Previous Close1,181
- Volume151483
Alembic Pharmaceuticals Investment Rating
-
Master Rating:
-
Alembic Pharmaceuticals has an operating revenue of Rs. 6,304.21 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 21% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 1,476 | 1,475 | 1,588 | 1,479 | 1,332 | 1,307 |
| Operating Expenses Qtr Cr | 1,184 | 1,186 | 1,251 | 1,271 | 1,167 | 1,138 |
| Operating Profit Qtr Cr | 291 | 288 | 337 | 207 | 166 | 169 |
| Depreciation Qtr Cr | 69 | 69 | 69 | 67 | 66 | 74 |
| Interest Qtr Cr | 13 | 10 | 15 | 15 | 14 | 14 |
| Tax Qtr Cr | 37 | 14 | 23 | 0 | 0 | -47 |
| Net Profit Qtr Cr | 176 | 202 | 233 | 134 | 98 | 131 |
Alembic Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹1,155.65
- 50 Day
- ₹1,109.56
- 100 Day
- ₹1,055.80
- 200 Day
- ₹977.57
- 20 Day
- ₹1,133.70
- 50 Day
- ₹1,122.13
- 100 Day
- ₹1,030.98
- 200 Day
- ₹973.11
Alembic Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,220.88 |
| Second Resistance | 1,241.67 |
| Third Resistance | 1,259.33 |
| RSI | 58.39 |
| MFI | 80.88 |
| MACD Single Line | 21.19 |
| MACD | 29.86 |
| Support | |
|---|---|
| First Support | 1,182.43 |
| Second Support | 1,164.77 |
| Third Supoort | 1,143.98 |
Alembic Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 163,196 | 5,630,262 | 34.5 |
| Week | 266,117 | 9,827,716 | 36.93 |
| 1 Month | 439,820 | 12,477,699 | 28.37 |
| 6 Month | 330,263 | 10,555,195 | 31.96 |
Alembic Pharmaceuticals Result Highlights
Alembic Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5874.06 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2024. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.| Market Cap | 23,218 |
| Sales | 6,017 |
| Shares in Float | 5.90 |
| No of funds | 208 |
| Yield | 0.93 |
| Book Value | 4.73 |
| U/D Vol ratio | 3.1 |
| LTDebt / Equity | |
| Alpha | 0.09 |
| Beta | 0.83 |
Alembic Pharmaceuticals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 69.61% | 69.61% | 69.61% | 69.61% |
| Mutual Funds | 8.05% | 7.82% | 7.71% | 7.33% |
| Insurance Companies | 6.98% | 7.1% | 6.52% | 6.57% |
| Foreign Portfolio Investors | 4.32% | 4.46% | 4.52% | 4.51% |
| Financial Institutions/ Banks | 0.03% | 0.03% | 0.03% | 0.03% |
| Individual Investors | 7.48% | 7.41% | 8% | 8.24% |
| Others | 3.53% | 3.57% | 3.61% | 3.71% |
Alembic Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Chirayu Amin | Chairman & CEO |
| Mr. Pranav Amin | Managing Director |
| Mr. Shaunak Amin | Managing Director |
| Mr. R K Baheti | Director - Finance & CFO |
| Dr. Archana Hingorani | Independent Director |
| Mr. Ashok Barat | Independent Director |
| Mr. Jai Diwanji | Independent Director |
| Mr. Manish Kejriwal | Independent Director |
Alembic Pharmaceuticals Forecast
Price Estimates
Alembic Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results | |
| 2024-05-09 | Audited Results & Final Dividend | |
| 2024-02-05 | Quarterly Results | |
| 2023-11-07 | Quarterly Results | |
| 2023-08-04 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-15 | FINAL | Rs.11.00 per share(550%)Final Dividend |
| 2023-07-28 | FINAL | Rs.8.00 per share(400%)Final Dividend |
| 2022-08-18 | INTERIM | Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided) |
Alembic Pharmaceuticals FAQs
What is Share Price of Alembic Pharmaceuticals ?
Alembic Pharmaceuticals share price is ₹1,200 As on 18 September, 2024 | 02:33
What is the Market Cap of Alembic Pharmaceuticals ?
The Market Cap of Alembic Pharmaceuticals is ₹23589.5 Cr As on 18 September, 2024 | 02:33
What is the P/E ratio of Alembic Pharmaceuticals ?
The P/E ratio of Alembic Pharmaceuticals is 37.4 As on 18 September, 2024 | 02:33
What is the PB ratio of Alembic Pharmaceuticals ?
The PB ratio of Alembic Pharmaceuticals is 4.9 As on 18 September, 2024 | 02:33